Support program adds more platforms, lengthens support time; final service pack for SUSE Linux Enterprise 10 packages improvements and supports latest hardware.
The Rezidor Hotel Group, one of the fastest growing hotel companies worldwide, announces their first ski resort in Ukraine: The Radisson Blu Resort, Bukovel is scheduled to open in the winter season 2011/12 and adds 252 rooms to Rezidor’s solid pipeline.
The Rezidor Hotel Group, one of the fastest growing hotel companies worldwide, adds a further Park Inn flagship to its UK-portfolio and announces the Park Inn London Wembley. The 235 rooms-property is scheduled to welcome the first guests in Q2 2012.
Wolfgang M. Neumann (49) is Rezidor’s new Executive Vice President & Chief Operating Officer, effective May 9, 2011. He succeeds Jacques Dubois who leaves the company for personal reasons.
RWE Dea AG, Hamburg, is on a positive course: in fiscal 2010, the company boosted its earnings by 50 per cent. The operating result amounted to 305 million euros in the year 2010 (2009: 203 million euros).
Santhera Pharmaceuticals (SIX: SANN) announced today the publication of details on the mode of action of idebenone (brand name Catena) in PLoS ONE (Public Library of Sciences ONE)
Huntsman Corporation (NYSE: HUN) announced that it has completed its acquisition of Indian chemical producer Laffans Petrochemicals Ltd., and has taken ownership of the manufacturer's 60kt ethylene oxide derivatives facility in Ankleshwar, Gujarat.
Life Technologies Corporation (NASDAQ: LIFE) announced the launch of its TaqMan Mutation Detection Assays - highly sensitive and novel molecular analysis research tools with the precision to detect a single mutant molecule hiding in a background of 1 million normal copies.
Clinical Results from 101 Patients Show Low MACE Rate, No Blood Clots and Low Late Loss. In a Sub-Analysis, Nearly All Patients' Vessels Assessed for Vasomotor Function Showed Signs of Vasomotion at One Year.
Modern processes and harmonized operational structures contribute to long-term profitable growth. Focus on better service for customers, smoother processes and lower costs.
BASF globally increases prices for all nature-identical carotinoid formulations containing canthaxanthin, citranaxanthin, C30-ester and beta-carotene by approximately 12%, effective immediately or as existing commitments allow.
BASF, the world’s leading chemical company, has received approval for a 400,000 metric tons per year MDI (diphenylmethane diisocyanate) project in Chongqing, China. The investment will total RMB 8 billion (approximately €860 million). The facility, which will produce a core component mainly used for polyurethane foams, is expected to start up by 2014.
Novartis announced today that the US Food and Drug Administration (FDA) has extended the regulatory review period for QAB149 (indacaterol) for the once-daily long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
The Board of Executive Directors of BASF SE has decided as a first step to contribute €500,000 to the Central Community Chest of Japan as immediate aid to victims of the earthquake and tsunami in Japan. This donation will be provided by the BASF Social Foundation.
Effective immediately, or as existing contracts permit, BASF is raising its prices for propionic acid in Europe by 200 Euro per ton and in Asia by 200 US-Dollars per ton.
At the beginning of March, the first of two offshore installation vessels owned by RWE was officially launched after only seven months of construction.
Novartis has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for Lucentis® (ranibizumab) to treat patients with visual impairment due to macular edema secondary to retinal vein occlusion (RVO).
The European Commission has granted Novartis approval for Gilenya® (fingolimod) 0.5 mg daily as a disease modifying therapy in patients with highly active relapsing-remitting multiple sclerosis (RRMS) despite treatment with beta interferon, or in patients with rapidly evolving severe RRMS.
Novartis announced today that a pivotal Phase III trial of the investigational Janus kinase (JAK) inhibitor INC424 (ruxolitinib) has met its primary endpoint of significantly reducing spleen size in patients with myelofibrosis (MF). INC424 is a potent, selective inhibitor of the JAK1 and JAK2 tyrosine kinases.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of PVT Probenverteiltechnik GmbH based in Waiblingen, Germany and of PVT Lab Systems, LLC based in Atlanta, Georgia, USA. PVT is a global market leader in providing customised automation and workflow solutions for in-vitro diagnostic (IVD) testing in large commercial and hospital laboratories.
An advisory committee recommended today that the Food and Drug Administration (FDA) approve QAB149 (indacaterol) in the US as the first once-daily long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Tata Motors today launched the Tata Indica eV2, the most fuel efficient car in India with a mileage of 25 kmpl, certified by the Automotive Research Association of India (ARAI) for the CR4 diesel engine. Built on the Tata Indica platform, the Tata Indica eV2 succeeds the highly successful Tata Indica, India's favourite hatchback.
With immediate effect or as existing contracts permit, BASF is increasing its European sales prices for methylamines and methylamine derivates as follows:
A separation efficiency of 90 percent, high purity and much lower energy input: These are the results of the research project for CO2 scrubbing, which RWE Power, BASF and Linde are conducting together.
BASF SE, Ludwigshafen (Germany) and Evolva Holding SA, Reinach (Switzerland) today announced that they have signed an agreement for joint research on the design of novel and optimised biosynthesis routes for selected natural products with crop protection potential.
Dr. Uwe Liebelt (44) will become President of BASF’s Paper Chemicals division, located in Basel, Switzerland, effective April 1, 2011. Liebelt is currently Senior Vice President, Dispersions & Pigments North America located in Charlotte, North Carolina.
BASF intends to build an additional production plant for sodium methylate in South America. Argentina is the planned location for the second plant with an annual capacity of about 60,000 metric tons.
Delcam will demonstrate the latest version of its PartMaker software for programming turn-mill centres and Swiss-type lathes at PMTS 2011 in Columbus, Ohio, from 19th to 21st April.
Implant Direct, a leading manufacturer of dental implants based in Southern California, has slashed its programming and set-up times with Delcam’s PartMaker SwissCAM software for the programming of Swiss-type lathes.
Delcam’s VP of Software Development, Tom McCollough, appeared in the first of a new series of video interviews on MCADCafe.com, a targeted web site addressing the information needs of mechanical engineers, designers, and manufacturers.
The Board of Executive Directors of BASF SE has decided to propose to the Annual Meeting on May 6, 2011 a dividend of €2.20 per share for 2010. The decision is subject to approval by the company’s Supervisory Board in its meeting on March 3, 2011.
The Boards of HV Transmissions Limited (HVTL) and HV Axles Limited (HVAL) have decided to amalgamate HVTL into HVAL to harness synergies and graduate the two entities as a total driveline solutions provider, backed with appropriate skills and expertise.
Sanofi-Aventis (SASY.PA: Quote) has completed a review of the financial books and operations of takeover target Genzyme Corp (GENZ.O: Quote), but the two sides continue to discuss a final price for a potential deal, according to The Wall Street Journal.
Tata Motors has won a prestigious order for supplying around 250 Tata Prima trucks to LINFOX Logistics, the largest privately owned Supply Chain Solutions Company in the Asia Pacific region with over 50 years of experience in this business. LINFOX will ply these trucks in India.
BASF has started operations at its expanded plant for the production of the biodegradable plastic Ecoflex®. Expansion of the existing plant in Ludwigshafen will increase production capacity for Ecoflex from 14,000 to 74,000 metric tons per year.
In 2010, BASF’s research and development (R&D) expenditure reached a new record level, rising to nearly €1.5 billion (previous year 2009: €1.40 billion).
With effect from 1 February 2011, Michael Neff takes over as Chairman of the RWE IT Management Board and assumes the role of the CIO (Chief Information Officer) for the RWE Group. He succeeds Chittur S. Ramakrishnan who retired at the end of January 2011.
The Rezidor Hotel Group, one of the fastest growing hotel companies worldwide, has opened their new flagship in Sweden: the Radisson Blu Waterfront Hotel, Stockholm with direct connection to the Stockholm Waterfront Congress Centre – one of Scandinavia’s largest facilities for meetings and events.
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Gilenya® (fingolimod) 0.5 mg daily as a disease modifying therapy in patients with highly active relapsing-remitting multiple sclerosis (MS) despite treatment with beta interferon, or in patients with rapidly evolving severe relapsing-remitting MS.
The European Medicines Agency said Monday it was notified by Abbott Laboratories Limited (ABT) of its decision to withdraw its application for a centralized marketing authorization for the medicine Ozespa, briakinumab, 100 mg solution for injection.
Life Technologies Corporation (NASDAQ: LIFE) announced today it will report its fourth quarter and full year 2010 financial results on Thursday, February 3, 2011, after market close. The company will also hold a conference call on the same day at 4:30 p.m. EST to discuss operating results, as well as future expectations.
Hot water tanks can benefit from the energy-efficient potential of BASF's versatile foam Basotect®. The melamine resin foam is increasingly being used as external insulation for tanks made of stainless steel holding up to 500 liters of water. A key factor for this application is the foam's low thermal conductivity of less than 0.035 W/(m*K) and the resulting excellent thermal insulation.
Effective today, or as contracts allow, BASF increases prices globally for Zetag® flocculants and coagulants for Water treatment applications by a minimum of 5 to 15%.
BASLE - Acino has received the marketing authorization for its hydromorphone product in Germany. The German BfArM (Federal Institute for Drugs and Medical Devices) has completed the review and has approved Acino’s oral capsule formulation of hydromorphone 2mg, 4mg, 8mg, 16mg and 24mg (original prod-uct: Palladon retard / SR from Mundipharma).
BASEL - Erich Hunziker (born 1953), Chief Financial Officer, Chief Information Officer and Deputy Head of the Corporate Executive Committee has decided to retire from Roche at the end of March 2011 and plans to focus on a number of board memberships.
Delcam will demonstrate the latest additions to its range of software and hardware for the design and manufacture of dental restorations at the Dentistry Show to be held at the NEC, Birmingham, on 4th and 5th March.
ZUG, Switzerland - Foster Wheeler AG (Nasdaq: FWLT) announced today that a subsidiary of its Global Power Group has been awarded a contract by Ingeteam Power Plants, S.A. to design, supply and erect a bubbling fluidized-bed (BFB) steam generator and the associated auxiliary equipment for Biomasa de Cantabria.
With Irgacure® 270, BASF made a technological breakthrough in the development of cationic photoinitiators for packaging inks. For the first time, Irgacure® 270 now makes it possible to combine fast UV curing with very low emissions. This new product is very versatile, and its applications include both UV-curable printing inks and clear overprint varnishes.
American International Group, Inc. (NYSE: AIG) announced today that the condition to its previously announced dividend of approximately 75 million warrants has been satisfied. AIG also expects, assuming no material change in the relevant facts, circumstances and conditions, to close its previously announced recapitalization on January 14, 2011, although there can be no assurance in that regard.
Novartis Pharmaceuticals UK Ltd today announced that Lucentis(R) (ranibizumab) is being launched in the UK for the treatment of visual impairment due to diabetes, specifically diabetic macular oedema (DMO).
Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to its offer to acquire Dionex (NASDAQ: DNEX).
Partners In Health (PIH) and Abbott and its philanthropic foundation, the Abbott Fund, today announced a partnership to empower Haitians to create local solutions to the longstanding problem of severe malnutrition in Haiti
Agilent Technologies Inc. recently announced the industry's first commercially available 4G system design library for 3GPP Release 10 -- the W1918 LTE-Advanced library. The new system design library is available as an option to Agilent's SystemVue 2011.03 release software.
Bayer has submitted an application for marketing authorization to the European Medicines Agency (EMA) for the oral anticoagulant rivaroxaban in stroke prevention in patients with atrial fibrillation (SPAF), as well as for the treatment of deep vein thrombosis (DVT) and prevention of recurrent DVT and pulmonary embolism (PE).
Argenta today announced that it has entered into a drug discovery collaboration with Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) in the area of pain and inflammation.
Swisscom has decided to enter into a joint venture with the canton of Fribourg and the west Switzerland-based electricity producer and distributor Groupe E. The aim of this venture is to quickly and cost-effectively ensure connection to the fibre-optic network throughout the canton.
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced the acquisition of Sucampo AG (SAG), a Swiss-based patent-holding company and its wholly-owned subsidiary, Sucampo AG Japan (SAGJ), a patent maintenance company, from Ryuji Ueno, M.D., Ph.D., Ph.D., and Sachiko Kuno, Ph.D., co-founders and majority shareholders of Sucampo Pharmaceuticals, Inc. (SPI).
Sigma-Aldrich® Corporation (Nasdaq: SIAL) announced today it has acquired all outstanding shares of Cerilliant Corporation of Round Rock, Texas to strengthen the Company's analytical chemistry product portfolio and to continue to deliver on its strategic growth plans.
Following the publication of the AFEP-MEDEF Code of Corporate Governance for listed companies which includes recommendations on the conditions of executive compensation, Atos Origin, a leading IT services company, committed itself to implement these recommendations.
Dai Nippon Printing Co., Ltd. (DNP), NTT DOCOMO, INC. and CHI Group Co., Ltd. (CHI) announced today an agreement to establish on December 21 a joint-venture firm named 2Dfacto, Inc. that will begin selling electronic books online from early January 2011.
NTT DOCOMO, INC. announced that its Board of Directors resolved today on matters relating to its share repurchase under Article 156 of the Corporation Law, as applied pursuant to Article 165 (3) of the Corporation Law, as detailed below.
Denmark — EpiTherapeutics and Abbott today announced a collaboration agreement to develop new anti-cancer drugs by making small-molecule inhibitors against selected epigenetic oncology targets.
DSM has successfully completed process development and commenced cGMP manufacture of the Mayoly Spindler lipase compound for pre-clinical and Phase I clinical needs. DSM BioSolutions manufactures the lipase compound at its microbial fermentation facility located in Capua, Italy. DSM’s Capua facility is uniquely equipped for the production of microbial fermentation derived biological compounds
DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, today announces a license agreement with c-LEcta GmbH for proprietary screening technology.
Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure.
Abbott announced today that Abbott and AstraZeneca will discontinue their joint collaboration for the development of CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
After months of playing hardball with Sanofi-Aventis SA, Genzyme Corp. is displaying a new willingness to talk about price and other issues that have held up a deal, people familiar with the matter said.
Genzyme Corporation (NASDAQ: GENZ) today provided an extensive briefing on the market potential of alemtuzumab for multiple sclerosis at an event for investors and analysts in New York.
Effective today, or as contracts allow, BASF increases prices globally for additives and pigments for plastic applications by a minimum of 7-25% depending on product class.
BASF’s Catalysts division has entered into an agreement with Haldor Topsøe A/S, Denmark, to market Haldor Topsøe’s line of tail gas treatment catalysts for sulfur recovery units. Tail gas treatment catalysts are used to remove sulfur compounds as the last stage of a Claus sulfur recovery unit in order to meet local emission standards.
Progressing with their pledge to bring European beekeepers an effective solution to control the parasitic varroa destructor mite, BASF and NOD Apiary Products announced first results from official registration trials conducted in Europe.
Novartis announced today that it has entered into a definitive agreement with Alcon, Inc. (Alcon; NYSE: ACL) to merge Alcon into Novartis for Novartis shares and a Contingent Value Amount (CVA).
The potato starch manufacturer AVEBE and the plant biotechnology company BASF Plant Science announced today a research and development alliance in plant biotechnology.
Satisfied Users & 
Approved Press Releases
